ConductScience.org, home

Paper22322366

Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.

Burashnikov A and 4 others. Circ Arrhythm Electrophysiol, 2012. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol. Papers, record 22322366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22322366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
PubMed
Journal
Circ Arrhythm Electrophysiol
PubMed
Year
2012
PubMed
Publication types
Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
1.52
iCite
Revised in PubMed
2025-05-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Burashnikov AAlexander
2Pourrier MMarc
3Gibson JKJohn K
4Lynch JJJoseph J
5Antzelevitch CCharles

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcetanilidesMajor topic
AnisolesMajor topic
Heart AtriaMajor topic
PiperazinesMajor topic
PyrrolidinesMajor topic
Sodium ChannelsMajor topic
SotalolMajor topic
Action Potentials
Animals
Anti-Arrhythmia Agents
Dogs
Female
In Vitro Techniques
Male
Models, Animal
Ranolazine
Refractory Period, Electrophysiological
Sodium Channel Blockers
Time Factors

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 HL047678NHLBI NIH HHSUnited StatesR01HL047678PubMed and NIHNIH RePORTER
HL47678NHLBI NIH HHSUnited StatesR01HL047678PubMed and NIHNIH RePORTER
R55HL047678NIHNIH RePORTER

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118332267Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.Circulation2008https://conductscience.org/library/papers/18332267PubMed
219466903Atrial-selective sodium channel block for the treatment of atrial fibrillation.Expert Opin Emerg Drugs2009https://conductscience.org/library/papers/19466903PubMed
318670369New drugs targeting the cardiac ultra-rapid delayed-rectifier current (I Kur): rationale, pharmacology and evidence for potential therapeutic value.J Cardiovasc Pharmacol2008https://conductscience.org/library/papers/18670369PubMed
43973830Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers.J Pharmacol Exp Ther1985https://conductscience.org/library/papers/3973830PubMed
515630037Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat.Circulation2005https://conductscience.org/library/papers/15630037PubMed
69168779Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation.Circ Res1997https://conductscience.org/library/papers/9168779PubMed
718598958Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.Heart Rhythm2008https://conductscience.org/library/papers/18598958PubMed
811693771The repolarization-excitability relationship in the human right atrium is unaffected by cycle length, recording site and prior arrhythmias.J Am Coll Cardiol2001https://conductscience.org/library/papers/11693771PubMed
910533583Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model.Cardiovasc Res1999https://conductscience.org/library/papers/10533583PubMed
1015949471Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs.Cardiovasc Res2005https://conductscience.org/library/papers/15949471PubMed
1111153814Frequency-dependent electrophysiological effects of flecainide, nifekalant and d,l-sotalol on the human atrium.Jpn Circ J2001https://conductscience.org/library/papers/11153814PubMed
1216424796Characterization of the in vivo and in vitro electrophysiological effects of the novel antiarrhythmic agent AZD7009 in atrial and ventricular tissue of the dog.J Cardiovasc Pharmacol2006https://conductscience.org/library/papers/16424796PubMed
1321266917Vernakalant selectively prolongs atrial refractoriness with no effect on ventricular refractoriness or defibrillation threshold in pigs.J Cardiovasc Pharmacol2011https://conductscience.org/library/papers/21266917PubMed
1421841207A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion.Circ Arrhythm Electrophysiol2011https://conductscience.org/library/papers/21841207PubMed
1517371199Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent.Expert Opin Investig Drugs2007https://conductscience.org/library/papers/17371199PubMed
167491312Basic concepts in cellular cardiac electrophysiology: Part II: Block of ion channels by antiarrhythmic drugs.Pacing Clin Electrophysiol1995https://conductscience.org/library/papers/7491312PubMed
1721753258Atrial selective effects of intravenously administered vernakalant in conscious beagle dogs.J Cardiovasc Pharmacol2011https://conductscience.org/library/papers/21753258PubMed
1820179721New developments in atrial antiarrhythmic drug therapy.Nat Rev Cardiol2010https://conductscience.org/library/papers/20179721PubMed
1910840016Effects of experimental heart failure on atrial cellular and ionic electrophysiology.Circulation2000https://conductscience.org/library/papers/10840016PubMed
208222078Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents.Circ Res1993https://conductscience.org/library/papers/8222078PubMed

See all 38 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
36188606Open channel block of Kv1.5 channels by HMQ1611.Front Pharmacol2022https://conductscience.org/library/papers/36188606PubMed
34959701Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34959701PubMed
34577626New Strategies for the Treatment of Atrial Fibrillation.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34577626PubMed
33777481Effects of Ranolazine and its Combination with Amiodarone on Rapid Pacing-induced Reentrant Atrial Tachycardia in Rabbits.J Innov Card Rhythm Manag2021https://conductscience.org/library/papers/33777481PubMed
33165131Investigational Anti-Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?J Cardiovasc Pharmacol2020https://conductscience.org/library/papers/33165131PubMed
32453071The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.J Cardiovasc Pharmacol2020https://conductscience.org/library/papers/32453071PubMed
30455558Vernakalant versus ibutilide for immediate conversion of recent-onset atrial fibrillation.Hippokratia2017https://conductscience.org/library/papers/30455558PubMed
28175295Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.Europace2017https://conductscience.org/library/papers/28175295PubMed
27984585Atrial Heterogeneity Generates Re-entrant Substrate during Atrial Fibrillation and Anti-arrhythmic Drug Action: Mechanistic Insights from Canine Atrial Models.PLoS Comput Biol2016https://conductscience.org/library/papers/27984585PubMed
26820362Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis.Int J Cardiol2016https://conductscience.org/library/papers/26820362PubMed
25830485Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy.J Cardiovasc Pharmacol2015https://conductscience.org/library/papers/25830485PubMed
24821654The vernakalant story: how did it come to approval in Europe and what is the delay in the U.S.A?Curr Cardiol Rev2014https://conductscience.org/library/papers/24821654PubMed
24738652Vernakalant for the conversion of atrial fibrillation: the new kid on the block?Ann Noninvasive Electrocardiol2014https://conductscience.org/library/papers/24738652PubMed
24048630Antiarrhythmic drugs 2013: state of the art.Curr Cardiol Rep2013https://conductscience.org/library/papers/24048630PubMed
23732646Atrial selectivity of antiarrhythmic drugs.J Physiol2013https://conductscience.org/library/papers/23732646PubMed
23637539Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update.Vasc Health Risk Manag2013https://conductscience.org/library/papers/23637539PubMed
23108433Role of late sodium channel current block in the management of atrial fibrillation.Cardiovasc Drugs Ther2013https://conductscience.org/library/papers/23108433PubMed
22370957Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity.J Cardiovasc Pharmacol2012https://conductscience.org/library/papers/22370957PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22322366

GET https://conductscience.org/api/papers/v1/22322366/references?page=2